Medicines for the Treatment of Rare Diseases in the Republic of North Macedonia for the Period May 2026 – December 2028
N07XX06, tetrabenazine, 25 mg, tablet, tablet
N07XX06, tetrabenazine, 25 mg, tablet, tablet
M01CC01, penicillamine, 250 mg, tablet/capsule, tablet/capsule
M01CC01, penicillamine, 250 mg, tablet/capsule, tablet/capsule
A16AX07, sapropterin, 100 mg, tablet/powder for oral solution, tablet/sachet
A16AX07, sapropterin, 100 mg, tablet/powder for oral solution, tablet/sachet
C02DA01, diazoxide, 50 mg, capsule/hard tablet, capsule/hard tablet
C02DA01, diazoxide, 50 mg, capsule/hard tablet, capsule/hard tablet
N03AG04, vigabatrin, 500 mg, film-coated tablet/tablet for oral solution, tablet
N03AG04, vigabatrin, 500 mg, film-coated tablet/tablet for oral solution, tablet
N03AX17, stiripentol, 250 mg, hard capsule/powder for oral suspension, hard capsule/powder for oral suspension
N03AX17, stiripentol, 250 mg, hard capsule/powder for oral suspension, hard capsule/powder for oral suspension
L01EM03, alpelisib, 50 mg, film-coated tablet, tablet
L01EM03, alpelisib, 50 mg, film-coated tablet, tablet
A05AX04, maralixibat, 9.5 mg/1 ml, oral solution, bottle
A05AX04, maralixibat, 9.5 mg/1 ml, oral solution, bottle
R03DX09, mepolizumab, 100 mg/1 ml, solution for injection, pre-filled pen/syringe
R03DX09, mepolizumab, 100 mg/1 ml, solution for injection, pre-filled pen/syringe
L01XX74, belzutifan, 40 mg, film-coated tablet, tablet
L01XX74, belzutifan, 40 mg, film-coated tablet, tablet
C10AX13, evolocumab, 140 mg/1 ml, solution for injection, pre-filled pen/syringe
C10AX13, evolocumab, 140 mg/1 ml, solution for injection, pre-filled pen/syringe
